- Home
- CLDI vs MIRA Comparison
CLDI vs MIRA Comparison
Compare CLDI & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- MIRA
- Stock Information
- Founded
- CLDI 2014
- MIRA 2020
- Country
- CLDI United States
- MIRA United States
- Employees
- CLDI N/A
- MIRA N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- CLDI Health Care
- MIRA Health Care
- Exchange
- CLDI Nasdaq
- MIRA Nasdaq
- Market Cap
- CLDI 20.2M
- MIRA 19.5M
- IPO Year
- CLDI N/A
- MIRA 2023
- Fundamental
- Price
- CLDI $1.76
- MIRA $1.43
- Analyst Decision
- CLDI
- MIRA Strong Buy
- Analyst Count
- CLDI 0
- MIRA 1
- Target Price
- CLDI N/A
- MIRA $17.00
- AVG Volume (30 Days)
- CLDI 1.1M
- MIRA 312.4K
- Earning Date
- CLDI 08-08-2025
- MIRA 08-14-2025
- Dividend Yield
- CLDI N/A
- MIRA N/A
- EPS Growth
- CLDI N/A
- MIRA N/A
- EPS
- CLDI N/A
- MIRA N/A
- Revenue
- CLDI N/A
- MIRA N/A
- Revenue This Year
- CLDI N/A
- MIRA N/A
- Revenue Next Year
- CLDI N/A
- MIRA N/A
- P/E Ratio
- CLDI N/A
- MIRA N/A
- Revenue Growth
- CLDI N/A
- MIRA N/A
- 52 Week Low
- CLDI $1.61
- MIRA $0.73
- 52 Week High
- CLDI $46.68
- MIRA $2.70
- Technical
- Relative Strength Index (RSI)
- CLDI 29.56
- MIRA 45.66
- Support Level
- CLDI $1.61
- MIRA $1.36
- Resistance Level
- CLDI $6.06
- MIRA $1.56
- Average True Range (ATR)
- CLDI 0.77
- MIRA 0.08
- MACD
- CLDI -0.55
- MIRA -0.02
- Stochastic Oscillator
- CLDI 2.57
- MIRA 36.36
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.